COMP <GO>
IDYA vs NRIX // OPERATING MARGIN
IDEAYA Biosciences Inc. (NASDAQ) VS. Nurix Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: IDYA 7
— NRIX 1
■ METRIC PARITY
LAST: $31.96 (-2.83%) • MKT CAP: $3.17B
operating-margins
-60.00%
LAST: $26.80 (-1.18%) • MKT CAP: $2.96B
operating-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IDYA VS. NRIX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IDYA | NRIX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.80% | -35.00% | +21.20 | IDYA | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.31% | -8.89% | +6.58 | IDYA | /fcf-yield <GO> |
| Operating Margin ACTIVE | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -52.00% | -60.00% | +8.00 | IDYA | /net-margins <GO> |
| Revenue Growth (YoY) | 180.00% | 54.00% | +126.00 | IDYA | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 21.49 | 9.52 | +11.97 | IDYA | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 3/9 | +1.00 | IDYA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.0 | 65.6 | -25.60 | NRIX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $3.17B | $2.96B | $210.7M | IDYA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IDYA REV | NRIX REV | IDYA GROSS % | NRIX GROSS % | IDYA FCF | NRIX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $218.7M | $84.0M | — | — | -$73.5M | -$263.5M |
| FY 2024 | $7.0M | $54.5M | — | — | -$251.4M | -$181.9M |
| FY 2023 | $23.4M | $77.0M | — | — | -$115.2M | -$81.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IDYA // BETA —
NRIX // BETA —